Omega-3 and cardiovascular disease: Beyond the risk factors;Omega-3 y enfermedad cardiovascular: Más allá de los factores de riesgo

Nutricion Clinica y Dietetica Hospitalaria

Volumn 29, Issue 1, 2009, Pages 4-16

  Antonio, García Ríos ^a   Eugenia, Meneses María ^a   Pablo, Pérez Martínez ^a   Francisco, Pérez Jiménez ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Cardiovascular diseases; Eicosapentaenoic acid; Fish oil; Omega 3

Indexed keywords

EID: 77957711925     PISSN: 02116057     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Lloyd-Williams F, O'Flaherty M, Mwatsama M, Birt C, Ireland R, Capewell S. Estimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats. Bull World Health Organ. 2008 Jul; 86(7):535-541A
2. Rayner M, Petersen S. European cardiovascular disease statistics. British Heart Foundation: London. Available from: http://www.heartstats.org/homepage. asp [accessed on 12 February 2008]
3. Insull W Jr. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment. Am J Med. 2009 Jan; 122(1 Suppl):S3-S14
4. Jakobsen MU, O'Reilly EJ, Heitmann BL, Pereira MA, Bälter K, Fraser GE, Goldbourt U, Hallmans G, Knekt P, Liu S, Pietinen P, Spiegelman D, Stevens J, Virtamo J, Willett WC, Ascherio A. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr. 2009 Feb. 11
5. O'Keefe JH Jr, Cordain L. Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer. Mayo Clin Proc. 2004;79:101-108
6. Yashodhara BM, Umakanth S, Pappachan JM, Bhat SK, Kamath R, Choo BH. Omega-3 fatty acids: a comprehensive review of their role in health and disease. Postgrad Med J. 2009 Feb; 85(1000):84-90
7. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med Scand. 1972 Jul-Aug; 192(1-2):85-94
8. Bang HO, Dyerberg J, Hjoorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976;200:69-73
9. Iso H, Kobayashi M, Ishihara J, et al., JPHC Study Group. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation. 2006;113:195-202
10. Moore MJ, Glover BM, McCann CJ, et al. Demographic and temporal trends in out of hospital sudden cardiac death in Belfast. Heart. 2006;92:311-315
11. Guallar E, Sanz-Gallardo I, van't Veer P, Bode P, Aro A, Gómez-Aracena J, et al. Mercury, Fish Oils, and the Risk of Myocardial Infarction. N Engl J Med. 2002;347:1747-1754
12. Stern AH. Public health guidance on cardiovascular benefits and risks related to fish consumption. Environ Health. 2007 Oct. 23;6:31
13. US Food and Drug Administration. US Environmental Protection Agency. What You Need to Know About Mercury in Fish and Shellfish: 2004 EPA and FDA Advice for Women Who Might Become Pregnant, Women Who Are Pregnant, Nursing Mothers, Young Children. 2004. EPA 823-F04-009
14. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046-53
15. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and the risk of sudden cardiac death. JAMA. 1998;279:23-8
16. Yuan JM, Ross RK, Gao YT, Yu MC, Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol. 2001;154:809-16
17. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815-21
18. Mozaffarian D, Lemaitre RN, Kuller LH, Burke GL, Tracy R P, Siscovick DS. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107:1372-7
19. Harris WS. Extending the cardiovascular benefits of omega-3 fatty acids. Current Atheroscler Rep. 2005;7:375-80
20. Wang C, Harris WS, Chung M, et al. n-3 fatty acids from fish or fish-oil supplements, but not alpha-linoleic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. Am J Clinic Nutr. 2006;84:5-17
21. He K, Song Y, Daviglus ML, Liu et al. Fish consumption and incidence of stroke: a meta-analysis of cohort studies. Stroke. 2004;35:1538-42
22. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885-99
23. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of longchain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-8
24. He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality. A meta-analysis of cohort studies. Circulation. 2004;109:2705-11
25. Guallar E, Aro A, Jimenez FJ, Martin-Moreno JM, Salminen I, Van't Veer P, et al. Omega-3 fatty acids in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Arterioscler Thromb Vasc Biol. 1999;19:1111-8
26. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, et al. Dietary intake of linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890-7
27. London B, Albert C, Anderson ME, et al. Omega.3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation. 2007;116:e320-35
28. Block RC, Harris WS, Reid KJ, Sands SA, Spertus JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis. 2008 Apr; 197(2):821-8
29. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med. 2004 Jul; 39(1):212-20
30. Von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007 Jan 15; 73(2):310-5
31. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bovbjerg V, Arbogast P, Smith H, Kushi LH, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995 Nov. 1; 274(17):1363-7
32. GISSI-Prevenzione. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-55
33. Burr ML, Fehily AM, Gilbert J F, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet. 1989;2:757-61
34. Burr ML, Ashfield-Watt P A L, Dunstan F D J, Fehily AM, Breay P, Ashton T, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193-200
35. Ness AR, Ashfield-Watt P A L, Whiting JM, Smith GD, Hughes J, Burr ML. The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial. J Hum Nutr Diet. 2004;17:117-9
36. Yokoyama M, Origasea H, for the Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of Japan EPA Lipid Intervention Study (JELIS). Am Heart J. 2003;146:613-20 results reported as a "Late Breaking Clinical Trial" ata American Heart Association Scientific Sessions 2005 in Dallas, TX, USA
37. Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F, Lavezzari M, Stragliotto E, De Caterina R; ESPRIT Investigators. Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the Esapent for Prevention of Restenosis ITalian Study (ESPRIT). Am Heart J. 2002 Jun; 143(6):E5
38. Von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999 Apr. 6; 130(7):554-62
39. Erkkilä AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr. 2004 Sep; 80(3):626-32
40. Eritsland J, Arnesen H, Grønseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol. 1996 Jan 1; 77(1):31-6
41. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsh J, Holder D, Finnie K, Marquis J F, Naqvi S, Cohen E. Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study. Circulation. 1996 Oct. 1; 94(7):1553-60
42. Mozaffarian D, Psaty BM, Rimm EB, Lemaitre RN, Burke GL, Lyles M F, Lefkowitz D, Siscovick DS. Fish intake and risk of incident atrial fibrillation. Circulation. 2004 Jul. 27; 110(4):368-73
43. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL, Katan MB. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005 Sep. 27; 112(13):1945-52
44. Gissi-HF. Investigators, Tavazzi L, Maggioni A P, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct. 4; 372(9645):1223-30
45. Harper CR, Jacobson TA. Usefulness of Omega-3 fatty Acids and the prevention of coronary heart disease. Am J Cardiol. 2005;96:1521-1529
46. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002 Mar; 112(4):298-304
47. Hooper L, Thompson RL, Harrison RA, et al. Risks and benefits of omega-3 fats for mortality, cardiovascular disease and cancer: systematic review. BMJ. 2006;332:752-60
48. Yokoyama M, Origasa H, Matsuzaki M, et al. for the Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. LANCET. 2007;369:1090-8
49. Kris-Etherton PM, Harris WS, Appel LJ, for the AHA Nutrition Comité. Omega-3 fatty acids and cardiovascular disease. New recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151-152
50. Antman EM. ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction. 2004; disponible en www.acc.org
51. Smith SC, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006;113:2363-72
52. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J. 2003;24:1601-10
53. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. European Society of Cardiology update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2003;24:13-5
54. Van der Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acude Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66
55. Ernährung Gohlke H. Z Kardiol. 2005;94(Suppl 3):III/22-9
56. De Caterina R, Madonna R, Massaro M. Effects of omega-3 fatty acids on cytokines and adhesion molecules. Curr Atheroscler Rep. 2004;6:485-491
57. Schaefer MB, Wenzel A, Fischer T, Braun-Dullaeus RC, Renner F, Dietrich H, Schaefer CA, Seeger W, Mayer K. Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: impact on adhesion and apoptosis. Atherosclerosis. 2008 Apr; 197(2):630-7
58. Tagawa H, Shimokawa H, Tagawa T, Kuroiwa-Matsumoto M, Hirooka Y, Takeshita A. Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J Cardiovasc Pharmacol. 1999;33:633-640
59. Tagawa H, Hirooka Y, Shimokawa H, Hironaga K, Sakai K, Oyama J, Takeshita A. Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease. Hypertens Res. 2002 Nov; 25(6):823-9
60. Balk EM, Lichtenstein AH, Chung M, et al. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness and exercise tolerance: a systematic review. Atherosclerosis. 2006;184:237-246
61. Nishizawa H, Hamazaki K, Hamazaki T, et al. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In vivo. 2006;20:307-310
62. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J 3rd, Spur B W, Robinson DR, Corey EJ, Lewis RA, Austen K F. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med. 1985 May 9; 312(19):1217-24
63. Calper PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36:10007-24
64. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361:477-485
65. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol. 2004;24:1621-1627
66. Bellido C, Lopez-Miranda J, Blanco-Colio LM, Perez-Martinez P, Muriana FJ, Martin-Ventura JL et al. Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men. Am J Clin Nutr. 2004;80:1487-91
67. Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond). 2004;107:1-11
68. Seo T, Blazer WS, Deckelbaum RJ. Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr Opin Lipidol. 2005;16:11-18
69. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006 Nov; 189(1):19-30
70. Hartweg J, Farmer AJ, Perera R, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. Diabetologia. 2007 Aug; 50(8):1593-602
71. Hartweg J, Perera R, Montori V, Dinneen S, Neil HA, Farmer A. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2008 Jan 23; (1): CD003205
72. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002;25 Suppl 1:S50-60
73. American Heart Association Web site. Fish and omega-3 fatty acids: AHA recommendation. Disponible en: www.americanheart.org/presenter.jhtml?identifier= 4632
74. Hartweg J, Farmer AJ, Holman RR, Neil HA. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia. 2007 Feb; 50(2):250-8
75. Nair SS, Leitch J W, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr. 1997 Mar; 127(3):383-93
76. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005 Jun. 15; 293(23):2884-91
77. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D; Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005 Nov. 1; 112(18):2762-8
78. Brouwer IA, Zock PL, Camm AJ, Böcker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006 Jun. 14; 295(22):2613-9
79. Calo L, Bianconi L, Colivicchi F, Lamberte F, Loricchio ML, De Ruvo E et al. Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized controlled trial. J Am Coll Cardiol. 2005;45:1723-1725
80. Gillman M W, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993 Apr; 125(4):1148-54
81. O'Keefe JH Jr, Abuissa H, Sastre A, Steinhaus DM, Harris WS. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006 Apr. 15; 97(8):1127-30
82. Mozaffarian D, Stein PK, Prineas RJ, Siscovick DS. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation. 2008 Mar. 4; 117(9):1130-7
83. Jenkins DJ, Josse AR, Beyene J, Dorian P, Burr ML, La Belle R, Kendall CW, Cunnane SC. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ. 2008 Jan 15; 178(2):157-64
84. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008 Oct. 15;7:37
85. Swann PG, Venton DL, Le Breton GC. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Lett. 1989 Jan 30; 243(2):244-6
86. Vanschoonbeek K, Feijge Ma, Paquay M, Rosing J, Saris W, Kluft C, et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombina generation. Arterioscl Thromb Vasc Biol. 2004;24:1734-40
87. Mehta J, Lawson D, Saldeen TJ. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. Am Heart J. 1988;116:1201-6
88. Delbosc S, Glorian M, Le Port AS, Béréziat G, Andréani M, Limon I. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am J Pathol. 2008 May; 172(5):1430-40
89. Delgado-Lista J, Lopez-Miranda J, Cortés B, Perez-Martinez P, Lozano A, Gomez-Luna R, Gomez P, Gomez MJ, Criado J, Fuentes F, Perez-Jimenez F. Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal. Am J Clin Nutr. 2008 Feb; 87(2):317-22
90. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers J W, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association and the Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140
91. Schmier JK, Rachman NJ, Halpern M T. The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events. Manag Care. 2006 Apr; 15(4):43-50
92. Harris WS. Are omega-3 fatty acids the most important nutritional modulators of coronary heart disease risk?. Curr Atheroscler Rep. 2004 Nov; 6(6):447-52
93. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, et al. Polyunsaturated PUFAs in the food chain in the United States. Am J Clin Nutr. 2000;71:S179-88
94. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol. 2008 Feb; 19(1):57-62
95. Willett WC. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med (Hagerstown). 2007 Sep; 8 Suppl 1: S42-5
96. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP. Conversion of α-linolenic acid in humans is influenced by the absolute amounts of α-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr. 2006;84:44-53
97. Barcelona, February 1-2, 2009. Summary Statement International Expert Meeting Health significance of fat quality of the diet. www.iuns.org/features/ IUNS%20and%20Unilever/Complete%20 Summary%20Statement%20of%20IEM.pdf